Systemic Therapies For Advanced Hcc

Summary

Panelists Ghassan K. Abou-Alfa, MD; Amit G. Singal, MD; and Richard Finn, MD, outline patient and disease factors to consider ... Arndt Vogel, MD, Hannover Medical School, Hanover, Germany, explores future therapies and An interview with Dr. John D. Gordan from the University of California, San Francisco, and Dr. Michal G. Rose from Yale Cancer ... Considerations for combining chemoembolization with Advanced hepatocellular carcinoma At the 2025 American Society of Clinical Oncology Gastrointestinal Cancers Symposium, Boris Pasche, MD, PhD, ... Liver cancers are on the rise in the Western part of the world. Johns Hopkins has a multidisciplinary Decoding GI-HPB Oncology” 18 August 2021, Wednesday, 7 PM Webisode 18: Primary Liver Cancers Session (5/6): Chair, Matthew S. Johnson, MD, FSIR, discusses Richard S. Finn, MD, comments on the use of liver-directed Prof Hesham El-Ghazaly speaks to ecancer at the 2019 International Gastrointestinal, Liver and Uro-Oncology Conference ... Jeroen Dekervel, MD, PhD, KU Leuven, Leuven, Belgium, comments on factors affecting individualized first-line Case Scenarios to Integrate Recent Progress There has been remarkable progress in the Practice-Changing Updates in Different Settings of